XML 36 R22.htm IDEA: XBRL DOCUMENT v3.25.2
Segmentation of key figures (Tables)
 6 Months Ended
Jun. 30, 2025
Operating Segments [Abstract]  
Disclosure of segment information
Net sales and other revenues by segment
Three months ended June 30Six months ended June 30
($ millions)2025202420252024
Surgical
Implantables456 464 876 897 
Consumables777 736 1,489 1,422 
Equipment/other222 223 421 442 
Total Surgical net sales1,455 1,423 2,786 2,761 
Vision Care
Contact lenses692 636 1,380 1,307 
Ocular health430 423 862 858 
Total Vision Care net sales1,122 1,059 2,242 2,165 
Total net sales2,577 2,482 5,028 4,926 
Surgical other revenues— — 1 — 
Vision Care other revenues
19 14 40 29 
Total other revenues19 14 41 29 
Total net sales and other revenues2,596 2,496 5,0694,955 
Segment contribution and reconciliation to income before taxes
The below tables summarize segment contribution, including material items of income and expense as required by IFRS 8, Operating Segments, and the associated IFRIC agenda decision published in July 2024. The below tables also include a reconciliation of segment contribution to Income before taxes.
SurgicalVision CareNot allocated to segmentsTotal
Three months ended June 30
Three months ended June 30
Three months ended June 30
Three months ended June 30
($ millions)20252024202520242025202420252024
Net sales1,455 1,423 1,122 1,059 — — 2,577 2,482 
Other revenues— — 19 14 — — 19 14 
Cost of net sales(553)(510)(416)(422)(227)(176)(1,196)(1,108)
Cost of other revenues— — (12)(14)— — (12)(14)
Selling, general & administration(372)(368)(415)(390)(83)(79)(870)(837)
Research & development(152)(142)(90)(67)(3)(11)(245)(220)
Other income— — — — 5 5 5 5 
Other expense— — — — (31)(4)(31)(4)
Segment contribution and Operating income378 403 208 180 (339)(265)247 318 
Interest expense(51)(50)(51)(50)
Other financial income & expense4 12 4 12 
Share of (loss) from associated companies(1)— (1)— 
Income before taxes199 280 
SurgicalVision CareNot allocated to segmentsTotal
Six months ended June 30
Six months ended June 30
Six months ended June 30
Six months ended June 30
($ millions)20252024202520242025202420252024
Net sales2,786 2,761 2,242 2,165 — — 5,028 4,926 
Other revenues1 — 40 29 — — 41 29 
Cost of net sales(1,049)(980)(813)(838)(405)(353)(2,267)(2,171)
Cost of other revenues(1)— (30)(28)— — (31)(28)
Selling, general & administration(728)(720)(788)(758)(167)(161)(1,683)(1,639)
Research & development(295)(272)(162)(132)(10)(15)(467)(419)
Other income— — — — 154 11 154 11 
Other expense— — — — (60)(23)(60)(23)
Segment contribution and Operating income714 789 489 438 (488)(541)715 686 
Interest expense(100)(95)(100)(95)
Other financial income & expense13 24 13 24 
Share of (loss) from associated companies(15)— (15)— 
Income before taxes613 615 
Disclosure of net sales by region
Net sales by region(1)
Three months ended June 30Six months ended June 30
($ millions unless indicated otherwise)2025202420252024
United States1,160 45 %1,141 46 %2,297 46 %2,290 46 %
International1,417 55 %1,341 54 %2,731 54 %2,636 54 %
Net sales2,577 100 %2,482 100 %5,028 100 %4,926 100 %
(1)     Net sales by location of third-party customer.